Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute
Beijing, China/Beijing

Disclosures:

Presentations

Sep 28

2529 - Efficacy and Safety of Hypofractionated Radiotherapy Plus Sequential Chemotherapy with Immunotherapy in Patients with Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer
Hall F
04:45pm - 06:00pm PT